Activity of Type II RAF Inhibitor Tovorafenib in a Pediatric Patient With a Recurrent Spindle Cell Sarcoma Harboring a Novel SNX8-BRAF Gene Fusion.

Authors :: Offer K
McGuire MT
Song K
Goldfischer MJ
Davare MA
Corless CL
Beadling C
Neff T
Cox MC
Govinda Raju S
Blackman SC
Source :: JCO precision oncology [JCO Precis Oncol] 2023 Jul; Vol. 7, pp. e2300065.
Publication Year :: 2023

Subjects :: Child
Humans
Biomarkers, Tumor genetics
Gene Fusion
Neoplasm Recurrence, Local drug therapy
Neoplasm Recurrence, Local genetics
Sorting Nexins genetics
Proto-Oncogene Proteins B-raf genetics
Sarcoma drug therapy
Sarcoma genetics

Full Text Access

Tools